Nautilus Biotechnology, Inc.·4

Aug 16, 8:19 PM ET

Murphy Matthew B. 4

4 · Nautilus Biotechnology, Inc. · Filed Aug 16, 2022

Insider Transaction Report

Form 4
Period: 2022-08-12
Murphy Matthew B.
General Counsel
Transactions
  • Purchase

    Common Stock

    2022-08-15$2.84/sh+7,500$21,30854,140 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2022-08-12$2.85/sh+2,500$7,12546,640 total(indirect: See Footnote)
Holdings
  • Common Stock

    1,250
Footnotes (2)
  • [F1]Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
  • [F2]1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wf-form4_166069554291105.xmlPrimary

    FORM 4